Trigg Leslie 4
Research Summary
AI-generated summary
Outset Medical (OM) CEO Leslie Trigg Sells 3,445 Shares
What Happened Leslie Trigg, Chair and CEO (also a director) of Outset Medical, sold 3,445 shares of common stock on 2026-05-15 at $3.70 per share, generating proceeds of $12,747. The sale was a "sell-to-cover" to satisfy tax withholding related to the vesting of RSUs and not a discretionary market trade.
Key Details
- Transaction date and price: 2026-05-15 — 3,445 shares sold at $3.70/share (total $12,747).
- Report filed: Form 4 filed on 2026-05-19 (reporting period 2026-05-15). The filing was marked late (transactionTimeliness = 'L').
- Shares owned after transaction: Not specified in the information provided. See the filed Form 4 for full holdings.
- Footnote F1: Sale required to cover tax withholding for vesting of an aggregate 9,319 RSUs granted on Jan 12, 2024 and June 10, 2025; transaction was a sell-to-cover and not discretionary.
- Footnote F2: Corrects an earlier Form 4 (filed Feb 19, 2026) that misstated a prior tax-withholding sale (reported 3,361 shares; corrected to 3,384 shares).
Context Sell-to-cover transactions are routine tax-withholding actions when RSUs vest and do not necessarily reflect the insider's view of the company. This filing corrects a prior reporting error and indicates the most recent withholding sale; note the Form 4 was filed after the transaction date.